Cyprus - Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes and Compulsory Contributory Health Care Financing Schemes
Since 2014, Cyprus Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes and Compulsory Contributory Health Care Financing Schemes rose 1.4% year on year. In 2019, the country was number 32 comparing other countries in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes and Compulsory Contributory Health Care Financing Schemes with €50.16 Per Capita. Cyprus is overtaken by Bulgaria, which was number 31 with €56.22 Per Capita and is followed by Bosnia and Herzegovina with €42.73 Per Capita. Switzerland topped the ranking with €666.37 Per Capita in 2019, +3.2% versus 2018. Germany, Liechtenstein and Ireland respectively ranked number 2, 3 and 4 in this ranking. Latvia recorded the best 5 years average growth at +8.8% per year, while Romania witnessed the worst performance at -1.7% per year.
Loading...
| Date | Euros Per Capita |
|---|---|
| 2019 | 50.16 |
| 2018 | 51.94 |
| 2017 | 46.08 |
| 2016 | 49.72 |
| 2015 | 46.46 |
How does Cyprus rank in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes and Compulsory Contributory Health Care Financing Schemes?
| # | 33 Countries | Euros Per Capita | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Switzerland
|
666.37 | 2019 | +3.1 % | +5.3 % | View data | |
| 2 |
#2
Germany
|
553.39 | 2019 | +2.3 % | +3.0 % | View data | |
| 31 |
#31
Bulgaria
|
56.22 | 2019 | -0.3 % | +4.0 % | View data | |
| 32 |
#32
Cyprus
|
50.16 | 2019 | -3.4 % | +1.4 % | View data | |
| 33 |
#33
Bosnia and Herzegovina
|
42.73 | 2019 | +1.5 % | +3.5 % | View data | |